Neurobo Pharmaceuticals Inc (NRBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRBO | QNCX | PASG | ||
| Company | Neurobo Pharmaceuticals Inc | Quince Therapeutics Inc | Passage Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.35 | 1.2700 | 6.38 | ||
| High | 2.44 | 1.3700 | 6.44 | ||
| Low | 2.32 | 1.2600 | 5.96 | ||
| Latest | 2.36 | 1.3850 | 6.28 | ||
| Change | +0.01 | +0.1150 | +0.03 | ||
| % Change | +0.43% | +9.06% | +0.48% | ||
| Volume | 13,000 | 526,768 | 198,706 | ||
| 20-Day Average Volume | 35,165 | 12,405,959 | 108,427 | ||
| Previous Close | 2.35 | 1.2700 | 6.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.50 | 1.1977 | 8.69 | ||
| 20-Day Raw Stochastic | 22.27% | 16.53% | 5.21% | ||
| 20-Day Relative Strength | 40.86 | 37.66 | 40.54 | ||
| Weighted Alpha | -57.49 | -43.24 | -18.45 | ||
| Today's Opinion | 100% Sell | 88% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 48% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 11/20/24 | +7.24% since 04/14/26 | -42.63% since 04/14/26 | ||
| Low | 2.30 on 11/26/24 | 1.1200 on 04/15/26 | 5.98 on 04/21/26 | ||
| High | 2.54 on 11/25/24 | 1.4500 on 04/17/26 | 12.05 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -15.11% since 10/25/24 | +67.56% since 03/20/26 | -16.15% since 03/20/26 | ||
| Low | 2.18 on 11/15/24 | 0.8030 on 03/23/26 | 5.91 on 03/30/26 | ||
| High | 3.00 on 10/28/24 | 3.8430 on 04/08/26 | 12.05 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | -31.79% since 08/27/24 | -95.88% since 01/21/26 | -49.43% since 01/21/26 | ||
| Low | 2.08 on 10/10/24 | 0.8000 on 03/20/26 | 5.91 on 03/30/26 | ||
| High | 4.32 on 09/09/24 | 34.1020 on 01/27/26 | 14.10 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -42.86% since 05/24/24 | -92.63% since 10/21/25 | -28.80% since 10/21/25 | ||
| Low | 2.08 on 10/10/24 | 0.8000 on 03/20/26 | 5.91 on 03/30/26 | ||
| High | 5.30 on 06/27/24 | 45.4990 on 12/12/25 | 20.00 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,334 | 20,702 | 20,049 | ||
| Shares Outstanding, K | 8,616 | 16,301 | 3,208 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -12,470,000 | -83,980,000 | -45,520,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -5,650,000 | -39,460,000 | -12,980,000 | ||
| 60-Month Beta | -0.26 | 1.33 | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/07/24 | -4.30 on 04/10/26 | -4.08 on 03/03/26 | ||
| Latest Earnings Date | 03/27/25 | 05/12/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||